Tumour biomarkers: association with heart failure outcomes.

Purpose.The aims of the present study were (i) to investigate the impact of great age on pharmacokinetics of capecitabine and its metabolites and (ii) to evaluate

(b) Tumour volumes at day 50 of mice bearing MDA-MB-231 xenografts treated with vehicle, MMAE and 1.. (c) Mean body weights of each group of mice bearing

[25] reported the good prognostic value of ERCC1 high-intensity (above median value) tumour immunostaining, and the predictive value for lower overall survival of high expression

Biomarkers are needed to guide the standard of care, such as adjuvant chemotherapy in stage III colon cancer or neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal

Increasing  age  is  still  the  main  risk  factor  for  breast 

Ces deux interprétations ne sont pas nécessairement inconciliables. Face à la prise de conscience du phénomène et au règlement judiciaire d’une partie des situations

emergency department (ED) with heart failure and to describe the frequency of adverse events for patients presenting with various heart rate and systolic blood pressure values..

In this study, we aimed to test the previously reported associations of 102 genetic polymorphisms with survival outcomes of colorectal cancer patients in a separate patient cohort